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Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2 and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice 
INTRODUCTION
Diabetic kidney disease, or diabetic nephropathy (DN), is morphologically characterized by excessive deposition of extracellular matrix (ECM) with mesangial expansion, thickening of glomerular and tubular basement membranes, podocyte effacement and tubulointerstitial fibrosis.
Mechanistically, the development of DN has been associated with overactivation of the polyol pathway, overflux of the hexosamine pathway, marked alterations in intraglomerular hemodynamics, generation of advanced glycation products, activation of protein kinase C (PKC)/transforming growth factor-β (Tgfβ) signaling, and over-production of reactive oxygen species (ROS) etc. [1] [2] [3] [4] [5] [6] .
Aldose reductase (EC1.1.1.21, AR) is a member of the aldo-keto reductase protein family.
Being the first and the rate-limiting enzyme of the polyol pathway, AR is known to play crucial roles in the development of a variety of diabetic complications [7, 8] . The association of AR with the development of DN has recently been unequivocally demonstrated by us utilizing Ar knockout mice [9] . Interestingly, we showed that Ar deficiency ameliorated the development of DN in diabetic mice, predominantly by attenuating PKC and Tgfβ-induced fibrogenesis. Moreover, we also showed that Ar deficiency appeared to ameliorate diabetes-induced depletion of glutathione in the renal cortex.
However, the mechanisms through which AR mediates renal cortical Tgfβ and antioxidant defense signaling remained to be further investigated.
MicroRNAs (miRNAs) are small noncoding RNAs that are emerging as key regulators in the cellular signaling networks [10, 11] . The miR-200 miRNA family was initially thought to have five members, namely miR-200a, miR-141, miR-200b, miR-200c and miR-429 [12] . According to the newly-released miRBase (http://www.mirbase.org, Release 19), however, in mouse the five miR-200
genes probably each encode a -3p-seqeunce and a -5p-seqeunce respectively (Supplemental Fig S1) .
As such, human or mouse miR-200 family miRNAs reported in almost all previous publications actually represented exclusively the -3p-seqeunces (miR-200-3ps).
It is well established that miR-200-3ps play important roles in the development of many types of cancers through regulating cell differentiation, proliferation, invasion and migration etc. Moreover, these miRNAs were also found to be involved in insulin signaling [13] , antioxidant defense [11, [14] [15] [16] and fibrogenesis [5, [17] [18] [19] . miR-200a-3p/141-3p, in particular, were shown to target p38α
and modulate the oxidative stress response in ovarian cancer cells [14] . In breast and ovarian cancer cells, miR-200a-3p/141-3p were also found to interact with the 3'-untranslated region (3'UTR) of the mRNA of Kelch-like ECH-associated protein-1 (Keap1), a negative regulator of nuclear factor erythroid 2 p45-related factor-2 (Nrf2), causing dys-regulations in Nrf2-medaited antioxidant defense in cancer cells [15, 20] . Additionally, miR-200-3ps were reported to be transcriptionally regulated by Tgfβ1/2 [17, 18, [21] [22] [23] . Conversely, the activin receptor type 2B (ACVR2B), a member of the Tgfβ pathway, was identified as a single common target gene for miR-192/194/215 and miR-141-3p/200c-3p [24] . In deed, in nephroblastomas these miRNAs were shown to be significantly down-regulated, which was associated with an upregulation in ACVR2B mRNA. In rat proximal tubule epithelial NRK52E cells, miR-200a-3p/141-3p were also shown to repress the expression of Tgfβ2 via direct interaction with its 3'UTR [23] . Prompted by these and other findings, we hypothesized that in the renal cortex, AR might regulate the expression of miR-200-3ps to control antioxidant defense, Tgfβ1/2 and Zeb1/2 signaling. This study examined this hypothesis in cultured renal mesangial cells and in renal cortical tissues from diabetic mice that were either wild-type or deficient for Ar due to genetic manipulations [9] . p3AREs-luc, which is a human aldo-keto redutcase Akr7a3 gene promoter-luciferase reporter containing three antioxidant response elements (AREs) was as described previously [25] . p3TP-lux, which is Tgfβ-inducible reporter [26] , was a kind gift of Dr. Hongrui Wang of Xiamen University.
RESEARCH DESIGN AND METHODS

Plasmids and lentiviruses
Lentiviruses carrying shRNAs for Ar and an Ar-overexpressing pFlag-mAR and its control were prepared as described previously [27, 28] . LV-anti-miR-200a-3p) once every two weeks for one month. Urine was collected from 17-week old mice that were placed in metabolic cages for 24 h with free access to food and water. Urine volume was measured and the urine samples were centrifuged at 2,000 ×g for 20 min. The supernatants were stored at -80 °C before use. Urine albumin was measured using an ELISA kit from ADL (Beijing, China). Immediately following the collection of urine, 17-week old mice were sacrificed and both kidneys were rapidly dissected and weighted (wet weight) before kidneys were snap frozen and stored at -80 °C or put in 10% buffered formalin (v/v) before being embedded in paraffin. Kidney sections at 5 µm thickness were stained periodic acid-Schiff (PAS) and examined under a light microscope.
Cell culture, transient transfection and treatments
RNA extraction and real-time quantitative RT-PCR (qPCR) analysis of mRNAs and miRNAs.
Total RNA was isolated from the cultured cells and kidney tissues using TRIzol reagent (Invitrogen) according to the manufacturer's protocols. For mRNA quantification, reverse transcription was performed with TRIzol-extracted total RNA using a ReverTra Ace-α-® Kit as instructed (TOYOBO, Tokyo, Japan). qPCR was performed by using the SYBR Green Real-time PCR Master Mix (TOYOBO) and the StepOne Real-time qPCR system (Applied Biosystems Inc., Foster City, CA, USA) using the primer pairs listed in the Supplemental Table S3 and according to the manufacturer's protocols. The levels of mRNA expression were calibrated with the expression of 18S rRNA.
For miRNAs, qPCR was performed with the stem-loop primers as described previously [31] using the miRNA-specific reverse transcription primers, the universal primer and the miRNA-specific reverse LNA-primers described in Supplemental Table S4 . U6 RNA served as an endogenous control.
Luciferase reporter assays Luciferase reporter activities were determined using a Luciferase
Reporter Gene Assay System (Promega, Madison, WI, USA) as instructed. For all luciferase assays, β-galactosidase activities were determined to calibrate for the transfection efficiency. The calibrated value for a proper control was used to normalize all other values to obtain the normalized relative luciferase units (RLU) representing the activities of 3'UTR-containing luciferase reporters. (Fig 1A) , whereas both overexpression of Ar and inhibition of AR did not significantly affect the expression of cyclin-dependent kinase 4 (Cdk4), cyclin-dependent kinase 6 (Cdk6) and p27 Kip1 (Supplemental Fig S3) . Furthermore, the protein levels of Keap1, Nrf2, Tgfβ2 and Fn were significantly altered accordingly (Fig 1B and 1D ). To further demonstrate the effects of AR on the transcriptional activity mediated by Nrf2 or Tgfβ1/2, we performed transfection studies with an Nrf2-inducible p3AREs-luc [25] or a Tgfβ-inducible p3TP-lux luciferase reporter [26] Moreover, miR-200a-3p/141-3p were shown to be able to target Tgfβ2 to control renal fibrosis in rat proximal tubule epithelial cells [23] . These studies and our results as shown in Fig 1, Fig 2 (Fig 3C) , whereas inhibition of miR-200a-3p caused a significant up-regulation in the mRNA expression of Keap1, Tgfβ1/2, Col4
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and Fn but significant down-regulation in Nrf2 (Fig 3B) . Correspondingly, the protein expression of Tgfβ2 and two MREs were found on the 3'UTR of Fn (Supplemental Fig S2) . To demonstrate that miR-200a-3p/141-3p target Keap1, Tgfβ2 and Fn directly, we created four luciferase reporters, i.e., the full-length 3'UTR, a truncated 3'UTR that did not contain any putative MREs, a truncated 3'UTR that contain a single wild-type MRE and a truncated 3'UTR that contain a single mutated MRE, for each of the three putative target genes respectively (Supplemental Fig S2) . Co-transfection studies of GSH depletion, we assayed the levels of ROS and GSH in cultured Mes13 cells (Fig 5) . As expected, overexpression of Ar significantly increased but inhibition of AR significantly decreased the ROS production (Fig. 5A) . In contrast, overexpression of Ar significantly decreased but inhibition of AR significantly increased intracellular GSH (Fig 5B) . ::Ar -/-) mice [9] . The BT mice differ from the KO mice only in that in addition to the Ar knockout allele, the BT mice carry a knock-in transgene (KspAr +/-) in which a mouse kidney specific cadherin gene promoter drives the expression of Ar in a collecting tubule epithelial cell specific manner [9] . Remarkably, in comparison with that of the diabetic WT mice, renal cortical expression of miR-200a-3p/141-3p was significantly elevated in both the diabetic KO and diabetic BT mice ( Fig   6A) . Similarly, Ar deficiency was also shown to significantly elevate miR-200a-3p in the renal cortex of 11-week old db/db mice (Supplemental Fig S4) . Furthermore, with the elevations in miR-200a-3p/141-3p, the mRNA and protein expression of Keap1, Tgfβ1/2, Zeb1/2, Fn and Col4 were found to be greatly reduced whereas Nrf2 was greatly increased in the STZ-diabetic mice ( Fig   6B & 6C) , suggesting greatly enhanced Nrf2-mediated antioxidant defense and significantly (Fig 7C) . More interestingly, in vivo suppression of miR-200a-3p significantly elevated urinary albumin excretion in all diabetic mice received LV-anti-miR-200a-3p (Fig 7D) . In
Ar-deficient KO and BT mice received LV-anti-miR-200a-3p, however, the urinary albumin excretion was still lower than that of the WT mice received LV-anti-miR-200a-3p, indicating once again that AR inhibition was beneficial. Together these data further establish the important regulatory roles of miR-200a-3p in DN development or progression in diabetic animals.
DISCUSSION
In certain qPCR and Western blot analyses of this study, there were cases in which the sample number was relatively low (n = 3) due to the consideration of experimental handling. It is true that low sample number might potentially limit the interpretation of the statistical results. However, in our cases the data were often repeatedly cross-examined by multiple techniques and/or multiple models We showed previously that genetic deficiency of Ar counteracted the development of DN in C57BL/6 mice in part by attenuating Tgfβ-dependent fibrogenesis and hyperglycemia-induced oxidative stress [9] . Traditionally, it was thought that renal fibrogenesis is largely due to sustained diacyglycerol-induced activation of PKC-Tgfβ signaling [7, 32] . In our current study, we focused on whether and how AR might regulate fibrogenesis through mechanisms other than PKC-induced Tgfβ activation. We found that in cultured Mes13 cells, Ar overexpression down-regulated the expression of miR-200-3ps, whereas inhibition of AR by either ARI or shRNA-mediated Ar knockdown caused significant elevations in the expression of miR-200-3ps (Fig 2) . Importantly, we demonstrated that (Fig   4) . In Ar-deficient mice that had become diabetic for 17 weeks, the renal cortical expression of miR-200a-3p/141-3p in diabetic KO and BT mice was found to be greatly increased, which was also found to be associated with significant down-regulation in the mRNA and protein expression of Tgfβ2
and Fn (Fig 6) . We noticed that although Tgfβ1 is not a direct target of miR-200a-3p/141-3p, its expression was often co-regulated in the same direction with that of Tgfβ2, which is consistent with previous observations in rat tubule epithelial cells [23] . Oxidative stress is central to the development of diabetic complications [3, 4, 33, 34] , while hyperglycemia-induced overactivation of AR/the polyol pathway in particular is one of the major routes whereby oxidative stress is resulted in tissue sites prone to diabetic complications [35] [36] [37] .
Although hyperglycemia is thought to induce superoxide overproduction in the mitochondria [38] , overactivation of AR/the polyol pathway in the cytoplasm might contribute significantly to cellular redox imbalance as well [3, 36] . Specifically, overactivation of AR might lead to both increased ROS generation and reduced capacity in antioxidant defense [35, 36] . Recent data, however, also suggested that the disruption of antioxidant defense system might be the major cause for AR-induced oxidative stress [36] . Lines of evidence in support of this include: 1) In many types of diabetic tissues, overactivation of AR/the polyol pathway was often associated with glutathione depletion, which can be prevented or reversed by AR inhibition [39] [40] [41] ; 2) In many types of diabetic tissues, overactivation of AR/the polyol pathway was often associated down-regulation in antioxidant defense enzymes including catalase, superoxide dismutase, glutathione reductase and glutathione peroxidase [42] [43] [44] ; 3) Ablation of AR or inhibition of AR by ARIs were associated with the simultaneous restoration of multiple antioxidant defense enzymes [45] . Despite this, the mechanisms underlying the inverse correlation between AR expression and glutathione depletion and the co-regulation of multiple antioxidant enzymes by Ar overexpression or inhibition were not clear. Recent studies have shown that Nrf2 is an oxidative stress-responsive master transcription factor for many antioxidant defense enzymes [34, 46, 47] . Our current study, however, is the first to show that AR regulates miR-200a-3p/141-3p to post-transcriptionally control Keap1 to modulate Nrf2 signaling in renal cells, which provides a novel mechanism for the disruption of antioxidant defense under diabetic condition.
In this way, multiple Nrf2-regulated antioxidant defense enzymes are coordinately controlled by an AR-miR-200a-3p/141-3p-Keap1-Nrf2 signaling cascade such that when AR is activated these antioxidant enzymes will be suppressed but when AR is inhibited they will be quickly activated.
At first look, the regulation of Keap1, Tgfβ2 and Zeb1/2 by miR-200-3ps had been to some degree demonstrated either in cancer cells or other kidney cells or tissues. In diabetic kidneys, however, the expression of miR-200-3ps was not fully established before our study. For instance, in diabetic apoE knockout mice, miR-200a-3p/141-3p were shown to be significantly decreased to promote fibrogenesis in the kidney tissues [23] . In contrast, Kato et al. found that miR-200b-3p and miR-200c-3p were increased in the glomeruli of STZ-diabetic mice and db/db mice [21] . Moreover, while the roles of miR-200-3ps in cancer and other diseases were more clearly demonstrated, little data were available regarding how these miR-200-3ps might become dys-regulated. In our case, the central question was how miR-200-3ps were pathophysiologically regulated in the renal glomeruli. In our current study, we not only demonstrated that renal cortical miR-200a-3 or miR-141-3p were significantly down-regulated in both the STZ-diabetic mice and the db/db mice, we also showed that these miRNAs appeared to be regulated by AR. Our demonstration that AR is activated under hyperglycemia to suppress miR-200-3ps to coordinate Keap1-Nrf2, Tgfβ1/2 and Zeb1/2 signaling is of novel importance in part in that it provides a molecular mechanism through which miR-200-3ps become dys-regulated under diabetic conditions.
Interestingly, Ar itself is transcriptionally regulated by Nrf2 [48] and miR-200-3ps are regulated by Tgfβ1 [5] . Moreover, there are more cross-talks between oxidative stress, Tgfβ signaling, fibrogenesis, EMT and miR-200-3ps signaling [5, 10, 18, 23, 32, 34, 49, 50] . While the interplay of multiple signaling cascades implicating transcription factors, miRNAs, cytokines, and other regulatory signals illustrated the complexity of the signaling networks involved in the development of DN, it is important to distinguish the "leading" or forward cascades versus the "lagging" or feedback cascades. In this regard, in our opinion Tgfβ1-mediated transcription of miR-200-3ps is at most secondary to hyperglycemia-induced dysregulation in Tgfβ signaling and might represent a feedback rather than a leading event. Consistent with this, in this current study we showed that overexpression of Ar strongly and/or acutely repressed the expression of miR-200-3ps, which are able to regulate Tgfβ1/2 directly or indirectly. Additionally, in comparison with the appearance of redox imbalance under hyperglycemia, the activation of Tgfβ is a later event that might itself be triggered by oxidative stress [32, 34] . Assuming that high glucose-induced alterations in miR-200-3ps precede the appearance of overt oxidative stress as well as the activation of Tgfβ1/2, we propose a simplified model in an attempt to emphasize the "leading" signaling events rather than events that might represent feedback regulation. In this model (Fig 8) , The authors also thank Dr. Hongrui Wang of Xiamen University for the provision of p3TP-lux.
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